A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Conditions:   Classical Hodgkin Lymphoma;   Non-Hodgkin Lymphoma Intervention:   Biological: GEN3017 Sponsor:   Genmab Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials